Stay updated on Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden message, replacing the study details with an error screen while the site chrome remains visible. This indicates restricted access to the page's primary content.
    Difference
    17%
    Check dated 2026-09-23T00:53:51.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page shows an updated revision tag, upgrading from v3.6.6 to v3.7.0 to reflect a content refresh.
    Difference
    0.0%
    Check dated 2026-09-16T00:21:08.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new page revision tag v3.6.6 was added, replacing the previous v3.6.5, indicating a minor backend/template update.
    Difference
    0.0%
    Check dated 2026-09-01T19:47:38.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The NIH grant/contract year 2017 was added to the study identifiers. This supplements the existing EudraCT number with funding context for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T19:44:04.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page’s footer now displays Revision: v3.6.5, replacing the previous v3.6.4. This indicates a software update or patch applied to the page.
    Difference
    0.0%
    Check dated 2026-08-11T14:42:02.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a new release version. This appears to be a minor internal update with no user-facing content changes on the study page.
    Difference
    0.0%
    Check dated 2026-07-28T05:41:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.